- Home
- PWM vs EVGN Comparison
PWM vs EVGN Comparison
Compare PWM & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PWM
- EVGN
- Stock Information
- Founded
- PWM 2018
- EVGN 1999
- Country
- PWM Hong Kong
- EVGN Israel
- Employees
- PWM N/A
- EVGN N/A
- Industry
- PWM
- EVGN Agricultural Chemicals
- Sector
- PWM
- EVGN Industrials
- Exchange
- PWM Nasdaq
- EVGN Nasdaq
- Market Cap
- PWM 12.4M
- EVGN 11.6M
- IPO Year
- PWM 2023
- EVGN N/A
- Fundamental
- Price
- PWM $0.53
- EVGN $1.20
- Analyst Decision
- PWM
- EVGN Strong Buy
- Analyst Count
- PWM 0
- EVGN 1
- Target Price
- PWM N/A
- EVGN $3.50
- AVG Volume (30 Days)
- PWM 1.2M
- EVGN 47.5K
- Earning Date
- PWM 02-13-2026
- EVGN 08-19-2025
- Dividend Yield
- PWM N/A
- EVGN N/A
- EPS Growth
- PWM N/A
- EVGN N/A
- EPS
- PWM N/A
- EVGN N/A
- Revenue
- PWM $639,912.00
- EVGN $9,444,000.00
- Revenue This Year
- PWM N/A
- EVGN N/A
- Revenue Next Year
- PWM N/A
- EVGN $63.64
- P/E Ratio
- PWM N/A
- EVGN N/A
- Revenue Growth
- PWM 83.60
- EVGN N/A
- 52 Week Low
- PWM $0.31
- EVGN $0.95
- 52 Week High
- PWM $2.70
- EVGN $3.32
- Technical
- Relative Strength Index (RSI)
- PWM 54.53
- EVGN 43.77
- Support Level
- PWM $0.51
- EVGN $1.16
- Resistance Level
- PWM $0.58
- EVGN $1.29
- Average True Range (ATR)
- PWM 0.05
- EVGN 0.06
- MACD
- PWM -0.01
- EVGN -0.00
- Stochastic Oscillator
- PWM 24.34
- EVGN 23.53
About PWM Prestige Wealth Inc.
Prestige Wealth Inc is engaged in providing private wealth management services and asset management to high-net-worth and ultra-high-net-worth individuals and enterprises through its subsidiaries.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.